INTEGRATED BIOPHARMA INC Revenue from Contract with Customer, Including Assessed Tax
INTEGRATED BIOPHARMA INC (INBP) reported Revenue from Contract with Customer, Including Assessed Tax of $10.11 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2026-05-08
- INTEGRATED BIOPHARMA INC revenue from contract with customer, including assessed tax for the quarter ending 2026-03-31 was $10.11M, a 27.53% decline year-over-year.
- INTEGRATED BIOPHARMA INC revenue from contract with customer, including assessed tax for the quarter ending 2025-12-31 was $11.28M, a 10.58% decline year-over-year.
- INTEGRATED BIOPHARMA INC revenue from contract with customer, including assessed tax for the quarter ending 2025-09-30 was $12.69M, a 6.82% decline year-over-year.
- INTEGRATED BIOPHARMA INC revenue from contract with customer, including assessed tax for the quarter ending 2025-06-30 was $14.18M, a 11.21% increase year-over-year.
- INTEGRATED BIOPHARMA INC revenue from contract with customer, including assessed tax for fiscal 2025 was $54.35M, a 8.02% increase from fiscal 2024.
- INTEGRATED BIOPHARMA INC revenue from contract with customer, including assessed tax for fiscal 2024 was $50.32M, a 0.70% decline from fiscal 2023.
- INTEGRATED BIOPHARMA INC revenue from contract with customer, including assessed tax for fiscal 2023 was $50.67M, a 9.91% decline from fiscal 2022.
- INTEGRATED BIOPHARMA INC revenue from contract with customer, including assessed tax for fiscal 2022 was $56.25M, a 11.51% decline from fiscal 2021.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 9 month | Revenue from Contract with Customer, Including Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-03-31 | $10.11M 10-Q · filed 2026-05-08 | $21.39M derived: sum of 2 quarters · filed 2026-05-08 | $34.08M 10-Q · filed 2026-05-08 | $48.25M derived: sum of 4 quarters · filed 2026-05-08 |
| 2025-12-31 | $11.28M 10-Q · filed 2026-02-11 | $23.97M 10-Q · filed 2026-02-11 | $38.14M derived: sum of 3 quarters · filed 2026-02-11 | $52.09M derived: sum of 4 quarters · filed 2026-05-08 |
| 2025-09-30 | $12.69M 10-Q · filed 2025-11-10 | $26.86M derived: sum of 2 quarters · filed 2025-11-10 | $40.81M derived: sum of 3 quarters · filed 2026-05-08 | $53.42M derived: sum of 4 quarters · filed 2026-05-08 |
| 2025-06-30 | $14.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $28.12M derived: sum of 2 quarters · filed 2026-05-08 | $40.74M derived: sum of 3 quarters · filed 2026-05-08 | $54.35M 10-K · filed 2025-09-23 |
| 2025-03-31 | $13.95M 10-Q · filed 2026-05-08 | $26.56M derived: sum of 2 quarters · filed 2026-05-08 | $40.18M 10-Q · filed 2026-05-08 | $52.92M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $12.61M 10-Q · filed 2026-02-11 | $26.23M 10-Q · filed 2026-02-11 | $38.98M derived: sum of 3 quarters · filed 2026-02-11 | $52.12M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-09-30 | $13.62M 10-Q · filed 2025-11-10 | $26.36M derived: sum of 2 quarters · filed 2025-11-10 | $39.51M derived: sum of 3 quarters · filed 2025-11-10 | $51.02M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $12.75M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $25.89M derived: sum of 2 quarters · filed 2025-09-23 | $37.40M derived: sum of 3 quarters · filed 2025-09-23 | $50.32M 10-K · filed 2025-09-23 |
| 2024-03-31 | $13.15M 10-Q · filed 2025-05-14 | $24.66M derived: sum of 2 quarters · filed 2025-05-14 | $37.57M 10-Q · filed 2025-05-14 | $50.56M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $11.51M 10-Q · filed 2025-02-13 | $24.42M 10-Q · filed 2025-02-13 | $37.42M derived: sum of 3 quarters · filed 2025-02-13 | $50.52M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-09-30 | $12.91M 10-Q · filed 2024-11-13 | $25.91M derived: sum of 2 quarters · filed 2024-11-13 | $39.01M derived: sum of 3 quarters · filed 2024-11-13 | $51.26M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $12.99M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-20 | $26.09M derived: sum of 2 quarters · filed 2024-09-20 | $38.35M derived: sum of 3 quarters · filed 2024-09-20 | $50.67M 10-K · filed 2024-09-20 |
| 2023-03-31 | $13.10M 10-Q · filed 2024-05-10 | $25.35M derived: sum of 2 quarters · filed 2024-05-10 | $37.68M 10-Q · filed 2024-05-10 | $50.95M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $12.25M 10-Q · filed 2024-02-12 | $24.58M 10-Q · filed 2024-02-12 | $37.85M derived: sum of 3 quarters · filed 2024-02-12 | $53.48M derived: sum of 4 quarters · filed 2024-02-12 |
| 2022-09-30 | $12.33M 10-Q · filed 2023-11-09 | $25.59M derived: sum of 2 quarters · filed 2023-11-09 | $41.23M derived: sum of 3 quarters · filed 2023-11-09 | $55.82M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $13.27M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-15 | $28.90M derived: sum of 2 quarters · filed 2023-09-15 | $43.49M derived: sum of 3 quarters · filed 2023-09-15 | $56.25M 10-K · filed 2023-09-15 |
| 2022-03-31 | $15.63M 10-Q · filed 2023-05-11 | $30.23M derived: sum of 2 quarters · filed 2023-05-11 | $42.98M 10-Q · filed 2023-05-11 | $60.04M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $14.59M 10-Q · filed 2023-02-10 | $27.34M 10-Q · filed 2023-02-10 | $44.40M derived: sum of 3 quarters · filed 2023-02-10 | $61.48M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-09-30 | $12.75M 10-Q · filed 2022-11-10 | $29.81M derived: sum of 2 quarters · filed 2022-11-10 | $46.88M derived: sum of 3 quarters · filed 2022-11-10 | $61.14M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $17.06M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-13 | $34.13M derived: sum of 2 quarters · filed 2022-09-13 | $48.39M derived: sum of 3 quarters · filed 2022-09-13 | $63.56M 10-K · filed 2022-09-13 |
| 2021-03-31 | $17.07M 10-Q · filed 2022-05-12 | $31.33M derived: sum of 2 quarters · filed 2022-05-12 | $46.50M 10-Q · filed 2022-05-12 | $60.04M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $14.26M 10-Q · filed 2022-02-10 | $29.43M 10-Q · filed 2022-02-10 | $42.96M derived: sum of 3 quarters · filed 2022-02-10 | $56.59M derived: sum of 4 quarters · filed 2022-02-10 |
| 2020-09-30 | $15.17M 10-Q · filed 2021-11-10 | $28.71M derived: sum of 2 quarters · filed 2021-11-10 | $42.34M derived: sum of 3 quarters · filed 2021-11-10 | $56.53M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $13.54M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-02 | $27.17M derived: sum of 2 quarters · filed 2021-09-02 | $41.36M derived: sum of 3 quarters · filed 2021-09-02 | $52.77M 10-K · filed 2021-09-02 |
| 2020-03-31 | $13.63M 10-Q · filed 2021-05-13 | $27.83M derived: sum of 2 quarters · filed 2021-05-13 | $39.23M 10-Q · filed 2021-05-13 | $52.82M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $14.20M 10-Q · filed 2021-02-12 | $25.60M 10-Q · filed 2021-02-12 | $39.19M derived: sum of 3 quarters · filed 2021-02-12 | $53.27M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-09-30 | $11.41M 10-Q · filed 2020-11-12 | $24.99M derived: sum of 2 quarters · filed 2020-11-12 | $39.08M derived: sum of 3 quarters · filed 2020-11-12 | $51.08M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $13.58M derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-23 | $27.67M derived: sum of 2 quarters · filed 2020-09-23 | $39.67M derived: sum of 3 quarters · filed 2020-09-23 | $49.98M 10-K · filed 2020-09-23 |
| 2019-03-31 | $14.09M 10-Q · filed 2020-05-13 | $26.09M derived: sum of 2 quarters · filed 2020-05-13 | $36.39M 10-Q · filed 2020-05-13 | $48.96M derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | $12.00M 10-Q · filed 2020-02-12 | $22.30M 10-Q · filed 2020-02-12 | $34.87M derived: sum of 3 quarters · filed 2020-02-12 | $45.45M derived: sum of 4 quarters · filed 2020-02-12 |
| 2018-09-30 | $10.30M 10-Q · filed 2019-11-13 | $22.87M derived: sum of 2 quarters · filed 2019-11-13 | $33.44M derived: sum of 3 quarters · filed 2019-11-13 | $44.24M derived: sum of 4 quarters · filed 2019-11-13 |
| 2018-06-30 | $12.56M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-29 | $23.14M derived: sum of 2 quarters · filed 2019-08-29 | $33.94M derived: sum of 3 quarters · filed 2019-08-29 | $43.71M 10-K · filed 2019-08-29 |
| 2018-03-31 | $10.57M 10-Q · filed 2019-05-15 | $21.38M derived: sum of 2 quarters · filed 2019-05-15 | $31.14M 10-Q · filed 2019-05-15 | |
| 2017-12-31 | $10.80M 10-Q · filed 2019-02-13 | $20.57M 10-Q · filed 2019-02-13 |